Xylyx Bio is a biotechnology company located in Brooklyn, New York, specializing in innovative solutions within the life sciences sector. Situated at 760 Parkside Avenue, this company focuses on developing advanced biotechnological products and services that address complex challenges in healthcare and biological research. Its strategic position in Brooklyn allows it to collaborate with a diverse network of scientific professionals and institutions throughout the New York metropolitan area.
The company’s operations center around the research and development of novel biological compounds and techniques aimed at improving medical treatments and diagnostic processes. By leveraging cutting-edge technology and scientific expertise, Xylyx Bio contributes to the advancement of biotechnology through a range of laboratory and field applications. Its work encompasses molecular biology, biochemistry, and genetic engineering, reflecting the multidisciplinary nature of modern biotechnology.
Serving a broad client base that includes pharmaceutical firms, research laboratories, and healthcare providers, Xylyx Bio supports projects that require precise biological analysis and product development. The company’s team is composed of skilled scientists and technical specialists who employ rigorous methodologies to ensure the accuracy and reliability of their outcomes. This approach enables the company to maintain a strong presence in the competitive biotechnology industry within Brooklyn and beyond.
Xylyx Bio maintains open communication channels, including a direct phone line at 212-689-9005, facilitating engagement with clients and partners interested in biotechnological advancements. The company’s commitment to scientific progress and collaboration positions it as a noteworthy participant in the evolving landscape of biotechnology in New York.


































